Open AccessIn Reply
Author(s) -
Coomes Eric A.,
AlShamsi Humaid O.,
Meyers Brandon M.,
Alhazzani Waleed,
Alhuraiji Ahmad,
Chemaly Roy F.,
Almuhanna Meshari,
Wolff Robert A.,
Ibrahim Nuhad K.,
Chua Melvin L.K.,
Hotte Sebastien J.,
Elfiki Tarek,
Curigliano Giuseppe,
Eng Cathy,
Grothey Axel,
Xie Conghua
Publication year - 2020
Publication title -
the oncologist
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2020-0329
Subject(s) - medicine , pandemic , covid-19 , intensive care medicine , infectious disease (medical specialty) , disease
This letter to the editor remarks on additional considerations for the management of febrile neutropenia during the COVID‐19 pandemic, in response to the letter by Boutayeb et al.